Current report 30/2021 – Supplementing the documentation for the Ordinary General Meeting of Celon Pharma S.A. convened to take place on June 29, 2021

Legal basis: Article 56 subs. 1 point 2 of the Act on Public Offering - current and periodical information

As a supplement to current report 25/2021 dated June 2, 2021 announcing the Ordinary General Meeting of Celon Pharma S.A. convened to take place on June 29, 2021 along with draft resolutions, the Management Board of Celon Pharma S.A. ("Company") attaches hereto reports drawn up by the Supervisory Board, submitted to the Ordinary General Meeting of the Company:

- Annual written report of the Supervisory Board of Celon Pharma S.A. for the year 2020, the examination and approval of which constitute points 7 and 11 of the agenda for the Ordinary General Meeting,

- Report on remuneration of Members of the Management Board and the Supervisory Board of Celon Pharma S.A. for the years 2019 - 2020, for which an opinion is to be issued as point 14 of the agenda.